EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target

Lanlan Ma, Bingjun Lu, Yueqiao Si, Lingyan Dai, Mingyue Tan, Wujian Liu, Dongdong Sun, Jiangcheng Shu, Cong Chen, Qi Xiang, Dingsheng Jiang, Xiang Wei und 1 weitere

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Lanlan Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Southwest Hospital, Army Medical University, Chongqing, China; School of Medicine, Chongqing University, Chongqing, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Cathepsin K, Myocardium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Third Military Medical University Southwest Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dilated cardiomyopathy (DCM) is a leading cause of heart failure with a high mortality rate. Cardiac fibrosis plays a critical role in the progression of DCM, yet therapeutic strategies targeting fibrosis remain limited. Therefore, it is essential to investigate the underlying mechanisms of fibrosis in DCM. Our study demonstrates through the integration of weighted gene co-expression network analysis and gene ontology annotation that 35 biological processes, including cytokine production, were significantly associated with fibrosis in DCM. Protein-protein interaction analysis identified 82 crucial genes. The scRNA-seq identified cathepsin K (CTSK) as primarily expressed in cardiac fibroblasts. Masson's trichrome and immunofluorescence staining revealed that the level of fibrotic tissue in the left ventricle of patients with DCM and the expression of CTSK are higher than those in the normal ventricle. In vitro studies demonstrated that CTSK expression was upregulated in highly proliferative human cardiac fibroblasts (HCFs). PDGF-BB stimulation notably promoted HCF proliferation, an effect that was significantly attenuated by CTSK knockdown. However, CTSK depletion showed no inhibitory impact on TGF-β1-induced transdifferentiation of cardiac fibroblasts into myofibroblasts. Our research indicates that CTSK is a key regulator of myocardial fibrosis in DCM and is a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedCathepsin KMyocardiumHumansFibrosisFibroblastsCell ProliferationMaleMyofibroblasts

Stichwörter der Autor:innen

CTSKdilated cardiomyopathyfibrosishuman cardiac fibroblastsweighted gene Co-expression network analysis

Substanzen

Cathepsin KCTSK protein, human

Autor:innen und Institutionen

  • Department of Geriatrics, Southwest Hospital, Army Medical University, Chongqing, China; School of Medicine, Chongqing University, Chongqing, China.
  • Department of Geriatrics, Southwest Hospital, Army Medical University, Chongqing, China.
  • Department of Geriatrics, Southwest Hospital, Army Medical University, Chongqing, China; Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • School of Medicine, Chongqing University, Chongqing, China.
  • Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Geriatrics, Southwest Hospital, Army Medical University, Chongqing, China; School of Medicine, Chongqing University, Chongqing, China. Electronic address: weiericwang@163.com.

Förderung

  • National Key Research and Development Program of China
  • Third Military Medical University Southwest Hospital

Zitieren

APA

Ma, L., Lu, B., Si, Y., Dai, L., Tan, M., Liu, W., Sun, D., Shu, J., Chen, C., Xiang, Q., Jiang, D., Wei, X., & Wang, W. E. (2025). Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110421

Vancouver

Ma L, Lu B, Si Y, Dai L, Tan M, Liu W, et al. Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110421

BibTeX
@article{Ma2025,
  author = {Ma, Lanlan and Lu, Bingjun and Si, Yueqiao and Dai, Lingyan and Tan, Mingyue and Liu, Wujian and Sun, Dongdong and Shu, Jiangcheng and Chen, Cong and Xiang, Qi and Jiang, Dingsheng and Wei, Xiang and Wang, Wei Eric},
  title = {Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110421}
}
Kostenlos starten →